This issue of PET Clinics focuses on Imaging in Gynecologic Oncology, and is edited by Drs. Drew Torigian and Domenico Rubello. Articles will include: The role of CT and MRI in gynecologic oncology; The utility of ultrasonography in gynecologic oncology; FDG-PET assessment of cervical cancer; FDG-PET assessment of ovarian cancer; FDG-PET assessment of other gynecologic cancers; The role of PET imaging in gynecologic radiation oncology; The utility of non-FDG PET in gynecologic oncology; Normal variants and pitfalls encountered in PET assessment of gynecologic malignancies; The role and future of quantitative imaging assessment in gynecologic oncology; Emerging molecular imaging techniques in gynecologic oncology; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. CME Accreditation Page - p. xi 8. Preface - p. xiii 9. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology - p. 127 10. The Usefulness of Ultrasound Imaging in Gynecologic Oncology - p. 143 11. [18F]-2-Fluoro-2-Deoxy-D-glucose–PET Assessment of Cervical Cancer - p. 165 12. Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer - p. 179 13. FDG-PET Assessment of Other Gynecologic Cancers - p. 203 14. The Role of PET Imaging in Gynecologic Radiation Oncology - p. 225 15. Non–18F-2-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography in Gynecologic Oncology: An Overview of Current Status and Future Potential - p. 239 16. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies - p. 249 17. Quantitative Assessment of Gynecologic Malignancies - p. 269 18. Emerging Molecular Imaging Techniques in Gynecologic Oncology - p. 289
This issue of PET Clinics focuses on Imaging in Gynecologic Oncology, and is edited by Drs. Drew Torigian and Domenico Rubello. Articles will include: The role of CT and MRI in gynecologic oncology; The utility of ultrasonography in gynecologic oncology; FDG-PET assessment of cervical cancer; FDG-PET assessment of ovarian cancer; FDG-PET assessment of other gynecologic cancers; The role of PET imaging in gynecologic radiation oncology; The utility of non-FDG PET in gynecologic oncology; Normal variants and pitfalls encountered in PET assessment of gynecologic malignancies; The role and future of quantitative imaging assessment in gynecologic oncology; Emerging molecular imaging techniques in gynecologic oncology; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. CME Accreditation Page - p. xi 8. Preface - p. xiii 9. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology - p. 127 10. The Usefulness of Ultrasound Imaging in Gynecologic Oncology - p. 143 11. [18F]-2-Fluoro-2-Deoxy-D-glucose–PET Assessment of Cervical Cancer - p. 165 12. Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer - p. 179 13. FDG-PET Assessment of Other Gynecologic Cancers - p. 203 14. The Role of PET Imaging in Gynecologic Radiation Oncology - p. 225 15. Non–18F-2-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography in Gynecologic Oncology: An Overview of Current Status and Future Potential - p. 239 16. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies - p. 249 17. Quantitative Assessment of Gynecologic Malignancies - p. 269 18. Emerging Molecular Imaging Techniques in Gynecologic Oncology - p. 289
